Navigation Links
Breast Cancer Appears Less Deadly for Men Than Women

By Randy Dotinga
HealthDay Reporter

TUESDAY, Oct. 4 (HealthDay News) -- New research shows that the few men who develop breast cancer tend to have more advanced cases than women and to be diagnosed at an older age.

But when statistics are adjusted for factors such as age, men with breast cancer are less likely to die from the disease than women are.

The findings shed light on a rare disease in men, one that researchers had earlier assumed was deadlier for males.

"Men can develop it and should be aware that they should seek care if a breast lump develops," said study co-author Dr. Mikael Hartman, an assistant professor at National University of Singapore.

About 2,140 men in the United States will develop breast cancer this year, according to an estimate from the American Cancer Society (ACS), and about 450 men will die from it. The ACS estimates that the lifetime risk that a man will develop breast cancer is one in 1,000, although the likelihood skyrockets to 5 percent to 10 percent if a man has a mutation in a gene known as BRCA2, noted Dr. Mahmoud El-Tamer, an attending surgeon at Memorial Sloan-Kettering Cancer Center who studies male breast cancer.

The same mutation greatly boosts the risk of breast cancer in women.

It's not clear why breast cancer is much less common in men. Women, of course, have much more breast tissue. But volume doesn't appear to affect the risk of breast cancer in women, since those with large breasts don't develop the disease more than those with small breasts, El-Tamer said.

Estrogen could be key, study co-author Hartman said, since it seems to fuel breast cancer and is almost entirely absent in men.

In the new study, which appears online Oct. 3 in the Journal of Clinical Oncology, researchers analyzed statistics on breast cancer in both sexes in Denmark, Finland, Switzerland, Norway, Singapore and Sweden over the past 40 years. The researchers found 459,846 cases of breast cancer in women and 2,665 in men.

Women were diagnosed at age 62 on average and men at age 70. Men with breast cancer were less likely to live for five years than women with the disease were, but the situation reversed when researchers adjusted their statistics so they wouldn't be thrown off by differences between the two groups in terms of age and other factors.

Hartman said it's not clear why men do better, but it may have something to do with how their bodies react to anti-hormone and chemotherapy treatments. (Removal of the breast is another treatment for men with breast cancer.)

Over time, the prospects for women with breast cancer have improved at a greater rate than those for men, he said.

El-Tamer said men should be aware of the possible risk of breast cancer and see a doctor if they notice a lump or changes involving the nipple, such as an ulceration, discharge or changes in the areola.

More information

For more about male breast cancer, try the U.S. National Library of Medicine.

SOURCES: Mikael Hartman, M.D., Ph.D., assistant professor, National University of Singapore; Mahmoud El-Tamer, M.D., attending surgeon, Memorial Sloan-Kettering Cancer Center, New York City. Oct. 3, 2011, Journal of Clinical Oncology, online

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Exercise Tips for Breast Cancer Survivors
2. Nanotechnology holds promise for safer breast implants
3. Researchers call for more awareness of male breast cancer as cases rise
4. BPA exposure in utero may increase predisposition to breast cancer
5. Consider the breast and lungs when determining thoracic imaging protocols
6. Woman with a higher social standing and educational attainment breastfeed for longer
7. Red wine ingredient resveratrol stops breast cancer growth
8. Top honors for Dr. Armando E. Giuliano from one of the worlds leading breast cancer groups
9. Scientists shut down pump action to break breast cancer cells drug resistance
10. Breast-Feeding Boost: Fewer Hospitals Handing Out Free Formula
11. Women with breast cancer with no genetic link, are not fully utilizing breast cancer services
Post Your Comments:
Related Image:
Breast Cancer Appears Less Deadly for Men Than Women
(Date:10/12/2017)... LOS ANGELES (PRWEB) , ... October 12, 2017 ... ... of Parsa Mohebi Hair Restoration, has recently contributed a medical article to the ... doctors, on Dr. Mohebi’s article spotlights the hair transplant procedure known as ...
(Date:10/12/2017)... ... ... Leading pediatric oncology experts at Children’s National Health System will join ... International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired by Jeffrey Dome, ... at Children’s National, and Stephen P. Hunger, M.D., Chief of the Division of ...
(Date:10/12/2017)... ... October 12, 2017 , ... Women-owned and ... 2017 Best and Brightest in Wellness® by Best and Brightest. OnSite Wellness will ... Friday, Oct. 20 from 7:30 a.m. to 2 p.m. at the Henry Autograph ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... of $3,296 in property taxes a year. In some states—like New York, New ... , By contrast, many overseas retirement havens have extremely low property-tax rates, which ...
(Date:10/12/2017)... ... October 12, 2017 , ... Farm ... California Berkeley, and other leading institutions in announcing the launch of the ... change the way animals are raised for food. , Founding members of the ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... , Sept. 28, 2017 Hill-Rom Holdings, Inc. ... earnings conference call and webcast on Friday, November 3, ... (EDT) and ending at approximately 8:30 a.m. (CDT) / ... the company,s 2017 financial performance and guidance for 2018, ... initiatives to enhance operational performance, and long-range financial outlook ...
(Date:9/27/2017)... , Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), a leading global ... that its MyDario product is expected to appear on The Dr. Oz ... Dr. Oz Show airs in your area: ... The nine-time Emmy award-winning, The Dr. Oz Show kicked ... The segment features ...
(Date:9/23/2017)... -- Janssen Biotech, Inc. (Janssen) announced today that it ... Food and Drug Administration (FDA) for the Biologics License ... of moderately to severely active rheumatoid arthritis (RA). The ... to further evaluate the safety of sirukumab in the ... "We are disappointed by ...
Breaking Medicine Technology: